H. A. Dieterich

1.2k total citations
53 papers, 899 citations indexed

About

H. A. Dieterich is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, H. A. Dieterich has authored 53 papers receiving a total of 899 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Cardiology and Cardiovascular Medicine, 11 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Molecular Biology. Recurrent topics in H. A. Dieterich's work include Heart Failure Treatment and Management (14 papers), Blood Pressure and Hypertension Studies (13 papers) and Renin-Angiotensin System Studies (12 papers). H. A. Dieterich is often cited by papers focused on Heart Failure Treatment and Management (14 papers), Blood Pressure and Hypertension Studies (13 papers) and Renin-Angiotensin System Studies (12 papers). H. A. Dieterich collaborates with scholars based in Germany, United States and Switzerland. H. A. Dieterich's co-authors include Sujata Vaidyanathan, William P. Dole, Dan Howard, Ching‐Ming Yeh, Marie‐Noëlle Bizot, Venkateswar Jarugula, K. L�ffelholz, Christine Reynolds, Mojdeh Maboudian and H Gastpar and has published in prestigious journals such as The American Journal of Cardiology, Journal of Pharmacology and Experimental Therapeutics and Clinical Pharmacology & Therapeutics.

In The Last Decade

H. A. Dieterich

49 papers receiving 841 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. A. Dieterich Germany 17 571 396 155 93 90 53 899
HL Elliott United Kingdom 17 381 0.7× 147 0.4× 186 1.2× 126 1.4× 105 1.2× 57 876
Olga Schmidlin United States 19 451 0.8× 148 0.4× 167 1.1× 58 0.6× 46 0.5× 28 1.1k
Robert W. Piepho United States 13 218 0.4× 104 0.3× 107 0.7× 62 0.7× 54 0.6× 30 646
Stots B. Reele United States 12 367 0.6× 65 0.2× 145 0.9× 73 0.8× 97 1.1× 22 701
Deepak Gopal Shewade India 17 136 0.2× 132 0.3× 129 0.8× 102 1.1× 198 2.2× 68 708
J G Gerber United States 20 237 0.4× 123 0.3× 216 1.4× 281 3.0× 137 1.5× 47 1.2k
Peter C. Rubin United Kingdom 16 258 0.5× 89 0.2× 94 0.6× 68 0.7× 61 0.7× 48 868
Marie‐Laure Delporte Belgium 9 187 0.3× 145 0.4× 132 0.9× 67 0.7× 50 0.6× 14 872
A. D. Munro‐Faure United Kingdom 18 278 0.5× 108 0.3× 103 0.7× 50 0.5× 70 0.8× 27 798
Eva Steiness Denmark 20 478 0.8× 60 0.2× 300 1.9× 166 1.8× 108 1.2× 75 1.3k

Countries citing papers authored by H. A. Dieterich

Since Specialization
Citations

This map shows the geographic impact of H. A. Dieterich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. A. Dieterich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. A. Dieterich more than expected).

Fields of papers citing papers by H. A. Dieterich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. A. Dieterich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. A. Dieterich. The network helps show where H. A. Dieterich may publish in the future.

Co-authorship network of co-authors of H. A. Dieterich

This figure shows the co-authorship network connecting the top 25 collaborators of H. A. Dieterich. A scholar is included among the top collaborators of H. A. Dieterich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. A. Dieterich. H. A. Dieterich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ayalasomayajula, Surya, Ching‐Ming Yeh, Sujata Vaidyanathan, et al.. (2008). Effects of Aliskiren, a Direct Renin Inhibitor, on Cardiac Repolarization and Conduction in Healthy Subjects. The Journal of Clinical Pharmacology. 48(7). 799–811. 14 indexed citations
2.
Vaidyanathan, Sujata, Gian Camenisch, Christine Reynolds, et al.. (2008). Pharmacokinetics of the Oral Direct Renin Inhibitor Aliskiren in Combination With Digoxin, Atorvastatin, and Ketoconazole in Healthy Subjects: The Role of P‐Glycoprotein in the Disposition of Aliskiren. The Journal of Clinical Pharmacology. 48(11). 1323–1338. 87 indexed citations
3.
Vaidyanathan, Sujata, Michael G. Bartlett, H. A. Dieterich, et al.. (2008). Pharmacokinetic Interaction of the Direct Renin Inhibitor Aliskiren with Furosemide and Extended‐Release Isosorbide‐5‐Mononitrate in Healthy Subjects. Cardiovascular Therapeutics. 26(4). 238–246. 9 indexed citations
4.
Vaidyanathan, Sujata, Venkateswar Jarugula, H. A. Dieterich, Dan Howard, & William P. Dole. (2008). Clinical Pharmacokinetics and Pharmacodynamics of Aliskiren. Clinical Pharmacokinetics. 47(8). 515–531. 123 indexed citations
5.
Dieterich, H. A., et al.. (2008). A study of dose-proportionality in the pharmacokinetics of the oral direct renin inhibitor aliskiren in healthy subjects. International Journal of Clinical Pharmacology and Therapeutics. 46(5). 252–258. 25 indexed citations
6.
Vaidyanathan, Sujata, Christine Reynolds, Ching‐Ming Yeh, et al.. (2007). Pharmacokinetics, Safety, and Tolerability of the Novel Oral Direct Renin Inhibitor Aliskiren in Elderly Healthy Subjects. The Journal of Clinical Pharmacology. 47(4). 453–460. 43 indexed citations
7.
Vaidyanathan, Sujata, Jessica Valencia, Cathy Zhao, et al.. (2006). Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers. International Journal of Clinical Practice. 60(11). 1343–1356. 67 indexed citations
8.
Dieterich, H. A., et al.. (2006). PI-20Pharmacokinetic interaction of the oral renin inhibitor aliskiren with hydrochlorothiazide inhealthy volunteers. Clinical Pharmacology & Therapeutics. 79(2). P12–P12. 7 indexed citations
9.
Zwölfer, W., et al.. (1995). Enoximone versus epinephrine/nitroglycerin in cardiac low‐output states following valve replacement. Clinical Cardiology. 18(3). 145–149. 3 indexed citations
10.
11.
Buerke, Michael, H. A. Dieterich, Jennifer Meyer, & Harald Darius. (1992). Synergistic Platelet Inhibitory Effect of the Phosphodiesterase Inhibitor Piroximone and Iloprost. Birkhäuser Basel eBooks. 37. 71–77. 1 indexed citations
12.
Zerkowski, H.-R., U Freund, H. A. Dieterich, et al.. (1992). Low-Output Syndrome after Heart Surgery: Is a Monotherapy with Phosphodiesterase-III Inhibitors Feasible? A Comparitive Study of Amrinone and Enoximone. The Thoracic and Cardiovascular Surgeon. 40(6). 371–377. 8 indexed citations
13.
Thormann, J, A. Liebrich, Veselin Mitrović, et al.. (1992). Proof for Piroximoneʼs Inotropic Influence; Can it Safely be Used in Coronary Artery Disease? Analysis of End-Systolic Pressure-Volume Relations (Conductance Technique). Journal of Cardiovascular Pharmacology. 20(1). 50–62. 1 indexed citations
14.
Scholz, Hasso, H. A. Dieterich, & Wilhelm Schmitz. (1991). [Mechanism of the positive inotropic effect of phosphodiesterase inhibitors].. PubMed. 80 Suppl 4. 1–6. 1 indexed citations
15.
Klauß, Volker, Werner Zwehl, Harald Mudra, et al.. (1991). Short-term effects of oral enoximone on hemodynamics, exercise capacity, anaerobic threshold, and arrhythmias in congestive heart failure. Journal of Molecular Medicine. 69(10). 430–435. 3 indexed citations
16.
Orellano, L., et al.. (1990). Comparison of dobutamine and enoximone for low output states following cardiac surgery. International Journal of Cardiology. 28. S13–S19. 4 indexed citations
17.
18.
Fiegel, P., et al.. (1989). Pharmacokinetics of Intravenous Enoximone in Dialysis Patients. Journal of Cardiovascular Pharmacology. 14. S24–S24. 1 indexed citations
19.
Treese, Norbert, et al.. (1987). Long-term treatment with oral enoximone for chronic congestive heart failure: The European experience. The American Journal of Cardiology. 60(5). 85–90. 13 indexed citations
20.
Dieterich, H. A., et al.. (1976). The effects of physostigmine on cholinesterase activity, storage and release of acetylcholine in the isolated chicken heart.. Journal of Pharmacology and Experimental Therapeutics. 199(1). 236–246. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by HL Elliott Breakdown of academic impact, for papers by Olga Schmidlin Breakdown of academic impact, for papers by Robert W. Piepho Breakdown of academic impact, for papers by Stots B. Reele Breakdown of academic impact, for papers by Deepak Gopal Shewade Breakdown of academic impact, for papers by J G Gerber Breakdown of academic impact, for papers by Peter C. Rubin Breakdown of academic impact, for papers by Marie‐Laure Delporte Breakdown of academic impact, for papers by A. D. Munro‐Faure Breakdown of academic impact, for papers by Eva Steiness
Rankless by CCL
2026